SOLV
BalancerSolventum
$67.41
+2.48%
as of 13 Apr
Power Core
Solventum's moat is the validated clinical and regulatory embeddedness of its product portfolio across hospital workflows, coding systems, and manufacturing processes.
Direction of Movement
Lateral Trajectory Constrained by Debt and Technology Risk
ROC 200
-14.6%
SOLV
Solventum
$67.41
+2.48%
as of 13 Apr
DCF Fair Value: $149.56
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.
Company Profile
Solventum Corporation is a leading American healthcare company that emerged as an independent entity following its spin-off from 3M in April 2024. Built on over 70 years of healthcare innovation, Solventum develops, manufactures, and commercializes solutions aimed at addressing critical needs in the global medical community. The company's operations encompass four primary segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. Solventum's products and services support a diverse array of healthcare applications, from advanced medical and surgical equipment to digital dental solutions and health information systems, impacting both providers and patients. With a workforce exceeding 20,000 professionals and a presence in 38 countries, Solventum operates more than 300 offices and facilities worldwide. The corporation has established itself as a significant force in the global healthcare sector, consistently advancing new technologies and fostering partnerships to improve health outcomes. Solventum emphasizes sustainability, innovation, and addressing healthcare disparities, aiming to create a healthier future. Its substantial scale and diversified healthcare portfolio position it as a critical player in shaping industry standards and supporting the delivery of effective, safer patient care across international markets.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
20,584
Website
https://www.solventum.com